C2N Diagnostics

Saint Louis, MO · Founded 2007 · Privately Held (backing)

Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. C2N Diagnostics is based in Saint Louis, MO and was founded in 2007. It has raised $95 million across 2 recorded rounds; the latest was a $10 million early-stage round in May 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$95.0M
Last round
Early Stage VC
May 2025
Cap table — not yet on record

C2N Diagnostics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of C2N Diagnostics with a free account
  • ·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about C2N Diagnostics

Where does C2N Diagnostics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across C2N Diagnostics's 2 recorded funding rounds.